相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance
Manuel Buscarlet et al.
BLOOD (2014)
Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance
Rodrigo Jacamo et al.
BLOOD (2014)
Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML
Andrew Volk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts
Aruna Kode et al.
NATURE (2014)
Effects of Different Tissue Microenvironments on Gene Expression in Breast Cancer Cells
Gaelle Rondeau et al.
PLOS ONE (2014)
Plasma exosomes as markers of therapeutic response in patients with acute myeloic leukemia
Chang-Sook Hong et al.
FRONTIERS IN IMMUNOLOGY (2014)
In Vivo RNAi Screening Identifies a Leukemia-Specific Dependence on Integrin Beta 3 Signaling
Peter G. Miller et al.
CANCER CELL (2013)
Cytogenetic Nomenclature: Changes in the ISCN 2013 Compared to the 2009 Edition
A. Simons et al.
CYTOGENETIC AND GENOME RESEARCH (2013)
Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation
Junwei Shi et al.
GENES & DEVELOPMENT (2013)
Differential regulation of myeloid leukemias by the bone marrow microenvironment
Daniela S. Krause et al.
NATURE MEDICINE (2013)
Transglutaminase 2 expression in acute myeloid leukemia: Association with adhesion molecule expression and leukemic blast motility
Andrew Pierce et al.
PROTEOMICS (2013)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
Zheng Sun et al.
NATURE MEDICINE (2012)
Contribution of an Aged Microenvironment to Aging-Associated Myeloproliferative Disease
Virag Vas et al.
PLOS ONE (2012)
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity
Erdogan Taskesen et al.
BLOOD (2011)
Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts
Olga Blau et al.
BLOOD (2011)
Transglutaminase 2: A multi-tasking protein in the complex circuitry of inflammation and cancer
Kapil Mehta et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia
Marc H. G. P. Raaijmakers et al.
NATURE (2010)
Reserves, Functional, Immunoregulatory, and Cytogenetic Properties of Bone Marrow Mesenchymal Stem Cells in Patients with Myelodysplastic Syndromes
Mirjam Klaus et al.
STEM CELLS AND DEVELOPMENT (2010)
Interferon-γ and Tumor Necrosis Factor-α Differentially Affect Cytokine Expression and Migration Properties of Mesenchymal Stem Cells
Hatim Hemeda et al.
STEM CELLS AND DEVELOPMENT (2010)
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
Bruno Nervi et al.
BLOOD (2009)
Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q-syndrome
O. Lopez-Villar et al.
LEUKEMIA (2009)
The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance
Mark B. Meads et al.
CLINICAL CANCER RESEARCH (2008)
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Yujin Hoshida et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Leukemic Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic Progenitor Cells
Angela Colmone et al.
SCIENCE (2008)
Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes
Rosimeire A. Roela et al.
LEUKEMIA RESEARCH (2007)
Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia
Olga Blau et al.
EXPERIMENTAL HEMATOLOGY (2007)
Inappropriate notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes
Gergely Varga et al.
PATHOLOGY & ONCOLOGY RESEARCH (2007)
Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias
Zhihong Zeng et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8
A Ryningen et al.
LEUKEMIA RESEARCH (2005)
Mesenchymal stem cells in myelodysplastic syndromes:: phenotypic and cytogenetic characterization
E Flores-Figueroa et al.
LEUKEMIA RESEARCH (2005)
Bone marrow stroma in childhood myelodysplastic syndrome: composition, ability to sustain hematopoiesis in vitro, and altered gene expression
R Borojevic et al.
LEUKEMIA RESEARCH (2004)
Open source clustering software
MJL de Hoon et al.
BIOINFORMATICS (2004)
Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia
T Matsunaga et al.
NATURE MEDICINE (2003)
Reduction in drug-induced DNA double-strand breaks associated with β1 integrin-mediated adhesion correlates with drug resistance in U937 cells
LA Hazlehurst et al.
BLOOD (2001)
Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5)
SM Garrido et al.
EXPERIMENTAL HEMATOLOGY (2001)